Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
Joseph George, RN, Memorial Sloan Kettering Cancer Center presents at the 2023 International Symposium on Malignant Mesothelioma on palliative symptom management in patients with mesothelioma.
Making an impact on mesothelioma research, education, support and advocacy can include a variety of ways depending on a supporter’s comfort level and ability. Mackenzie
Lawyers Joseph Belluck of Belluck & Fox, and Dawn Besserman of MRHFM discuss legal issues surrounding a mesothelioma diagnosis. Moderated by Cheryl Bruner. https://youtu.be/JbP7hZPMyoA This is
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
